The North America balloon catheters market size was valued at USD 1.30 Billion in 2024 . It is expected to grow at a CAGR of 10.59% during the forecast period of 2025-2034, driven by the rising prevalence of cardiovascular diseases in the region. The market is estimated to reach a value of USD 3.56 Billion by 2034 .
Balloon catheters have an inflatable balloon at the tip, which can enlarge a narrow opening in a catheterization procedure. The minimally invasive nature of the device is attracting high demand in the market for various medical interventions such as angioplasty and stenting. With a rising patient inclination towards minimally invasive procedures due to certain benefits including reduced surgical trauma and shortened recovery time, North America balloon catheters market demand is expected to witness a surge in the forecast period.
The market is experiencing improvement in the regulatory landscape which boosts the growth. Faster regulatory approvals not only enhance access to novel balloon catheter products but also increase their adoption rates in the healthcare sector. In December 2023, the United States Food and Drug Administration (FDA) approved the Finesse Injectable angioplasty balloon catheters developed by Summa Therapeutics, LLC (a United States-based medical devices company), for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease. The Finesse product line includes a port for injecting radiopaque contrast material coupled with its performance of balloon angioplasty, making it an advanced toolset for angioplasty procedures. The availability of such innovative products in healthcare settings is anticipated to propel North America balloon catheters market share in the forecast period.
In December 2023, an Exclusive Commercial Agreement was signed between a medical equipment manufacturer in the United States, HR Pharmaceuticals, Inc. (HRP), and Poiesis Medical LLC (a medical device company in Florida). As per the terms of collaboration, HRP received the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America. This Dual Balloon Catheter technology is designed for patients enduring prolonged catheterization and exhibits better results as compared to traditional Foley Catheters. The increased access to such innovative balloon catheter products to the rising patient population in the region is likely to fuel market growth. The rise in strategic partnerships among the key market players which support the market expansion of balloon catheter devices marks as one of the most significant North America balloon catheters market trends.
Other factors that drive the market value include the presence of advanced infrastructure. The growing elderly population more prone to cardiovascular diseases is also poised to directly affect the market demand. Further, the existence of several leading market players and premium research institutions positively impacts the market landscape.
This product will be delivered within 3-5 business days.
Balloon catheters have an inflatable balloon at the tip, which can enlarge a narrow opening in a catheterization procedure. The minimally invasive nature of the device is attracting high demand in the market for various medical interventions such as angioplasty and stenting. With a rising patient inclination towards minimally invasive procedures due to certain benefits including reduced surgical trauma and shortened recovery time, North America balloon catheters market demand is expected to witness a surge in the forecast period.
The market is experiencing improvement in the regulatory landscape which boosts the growth. Faster regulatory approvals not only enhance access to novel balloon catheter products but also increase their adoption rates in the healthcare sector. In December 2023, the United States Food and Drug Administration (FDA) approved the Finesse Injectable angioplasty balloon catheters developed by Summa Therapeutics, LLC (a United States-based medical devices company), for the percutaneous transluminal angioplasty (PTA) treatment of peripheral artery disease. The Finesse product line includes a port for injecting radiopaque contrast material coupled with its performance of balloon angioplasty, making it an advanced toolset for angioplasty procedures. The availability of such innovative products in healthcare settings is anticipated to propel North America balloon catheters market share in the forecast period.
In December 2023, an Exclusive Commercial Agreement was signed between a medical equipment manufacturer in the United States, HR Pharmaceuticals, Inc. (HRP), and Poiesis Medical LLC (a medical device company in Florida). As per the terms of collaboration, HRP received the rights to commercialize Poiesis's Dual Balloon Catheter (Duette™) in North America. This Dual Balloon Catheter technology is designed for patients enduring prolonged catheterization and exhibits better results as compared to traditional Foley Catheters. The increased access to such innovative balloon catheter products to the rising patient population in the region is likely to fuel market growth. The rise in strategic partnerships among the key market players which support the market expansion of balloon catheter devices marks as one of the most significant North America balloon catheters market trends.
Other factors that drive the market value include the presence of advanced infrastructure. The growing elderly population more prone to cardiovascular diseases is also poised to directly affect the market demand. Further, the existence of several leading market players and premium research institutions positively impacts the market landscape.
North America Balloon Catheters Market Segmentation
“North America Balloon Catheters Market Report and Forecast 2025-2034” offers a detailed analysis of the market based on the following segments:Market Breakup by Product Type
- PTA Balloon Catheters
- PTCA Balloon Catheters
- Occlusion Balloon Catheters
- Foley Catheters
- Nephrostomy Balloon Catheters
- Drug-Eluting Catheters
- Normal Balloon Catheter
- Cutting Balloon Catheter
- Scoring Balloon Catheter
- Drug Eluting Balloon Catheter
- Stent Graft Balloon Catheter
- Others
Market Breakup by Catheter Type
- Fixed Wire
- Over-The-Wire
- Rapid Exchange
Market Breakup by Balloon Type
- Non-Compliant
- Semi-Compliant
- Compliant
Market Breakup by Material
- Polyurethane
- Nylon
- Others
Market Breakup by Indication
- Coronary Artery Disease
- Peripheral Vascular Disease
Market Breakup by End User
- Hospitals
- Specialty Clinics
- Others
Market Breakup by Region
- United States of America
- Canada
North America Balloon Catheters Market: Competitor Landscape
The key features of the market report include patent analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:- Abbott Laboratories
- Becton Dickinson and Company
- Boston Scientific Corporation
- Bard Medical Division
- B.Braun Melsungen AG
- Johnson & Johnson
- Teleflex Incorporated
- Medtronic, Plc.
- Edwards Lifesciences Corporation
- Vascular Solutions, Inc.
This product will be delivered within 3-5 business days.
Table of Contents
1 Preface
3 North America Balloon Catheters Market Overview
4 North America Balloon Catheters Market Landscape*
5 North America Balloon Catheters Market Dynamics
6 North America Balloon Catheters Market Segmentation (2018-2034)
7 United States of America Balloon Catheters Market (2018-2034)
8 Canada Ballon Catheters Market (2018-2034)
10 Patent Analysis
11 Funding and Investment Analysis
12 Partnership and Collaborations Analysis
13 Supplier Landscape
14 United States of America Cannula Market - Distribution Model (Additional Insight)
16 Company Competitiveness Analysis (Additional Insight)
17 Payment Methods (Additional Insight)
Companies Mentioned
- Abbott Laboratories
- Becton Dickinson and Company
- Boston Scientific Corporation
- Bard Medical Division
- B.Braun Melsungen AG
- Johnson & Johnson
- Teleflex Incorporated
- Medtronic, Plc.
- Edwards Lifesciences Corporation
- Vascular Solutions, Inc.